Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rh antigen, specifically the D antigen, is a protein found on the surface of red blood cells. Its presence or absence determines whether an individual is classified as Rh positive or Rh negative. It is clinically significant in transfusion medicine and obstetrics due to its high immunogenicity, leading to hemolytic transfusion reactions and hemolytic disease of the newborn. The precise physiological function of Rh proteins remains unclear but may involve ammonium transport across red cell membranes and maintenance of membrane integrity.
Anti-D immunoglobulin binds to RhD-positive fetal red blood cells in the maternal circulation, preventing the mother's immune system from recognizing them and producing anti-D antibodies. Blood transfusion interactions involve antigen-antibody reactions that lead to hemolysis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rh Antigen D (D).